← All themes

Genomics & Gene Editing

Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.

199 stocks

Gene Therapy

#	Name	Holding	Trade Value	Theme Stocks	% of Portfolio	Status
201	GW&K Investment Management Boston, Massachusetts	$413M	+$1.34M	16	3.23%	Increased
202	CI Investments Inc Toronto, Ontario, Canada	$412M	-$48.8M	10	1.32%	Reduced
203	Rockefeller Capital Management New York	$411M	-$14.8M	79	0.63%	Reduced
204	Cerity Partners New York	$410M	+$36.7M	53	0.5%	Increased
205	London & Capital Asset Management London, United Kingdom	$409M	+$10.3M	2	3.75%	Increased
206	SL Siren LLC Greenwich, Connecticut	$408M	-$7.28M	8	8.26%	Reduced
207	Fifth Third Bancorp Cincinnati, Ohio	$406M	-$28.7M	49	0.66%	Reduced
208	B Braidwell Stamford, Connecticut	$403M	-$127M	9	14.91%	Reduced
209	Frazier Life Sciences Management Palo Alto, California	$397M	-$67.4M	6	8.64%	Reduced
210	TCM Tang Capital Management San Diego, California	$385M	+$8.49M	7	17.48%	Increased
211	New York State Teachers Retirement System (NYSTRS) Albany, New York	$384M	-$16.8M	17	0.71%	Reduced
212	William Blair & Company Chicago, Illinois	$383M	-$41.1M	28	1%	Reduced
213	Korea Investment Corp Seoul, South Korea	$377M	+$14.7M	8	0.72%	Increased
214	Armistice Capital New York	$376M	+$13.8M	16	4.6%	Increased
215	Creative Planning Overland Park, Kansas	$370M	+$32.6M	77	0.22%	Increased
216	Eurizon Capital SGR SpA Milan,	$369M	+$49.3M	19	0.99%	Increased
217	Freestone Grove Partners San Francisco, California	$359M	+$154M	18	2.31%	Increased
218	Sessa Capital New York	$356M	-$285M	3	5.95%	Reduced
219	Troy Asset Management London, United Kingdom	$356M	+$32.1M	1	9.92%	Increased
220	Harvest Portfolios Group Oakville, Ontario, Canada	$352M	+$50.8M	5	4.96%	Increased
221	WorldQuant Millennium Advisors New York	$348M	+$152M	10	1.2%	Increased
222	Mariner Overland Park, Kansas	$347M	+$8.25M	52	0.36%	Increased
223	Edmond de Rothschild Holding Chambesy, Switzerland	$346M	-$24.8M	11	4.56%	Reduced
224	OrbiMed New York	$346M	-$47.3M	10	6.4%	Reduced
225	ACM Aisling Capital Management New York	$342M	-$35M	2	72.58%	Reduced